Podcast
Podcast
The Bioverge Podcast: Evolving Failures in an Evolving Pandemic and What Needs to Be Done
Dr. Eric Topol, founder and director of the Scripps Research Translational Institute, sits down with Neil to discuss the COVID-19 delta variant, our failures to evolve with the virus, and what steps need to be taken to combat the ongoing pandemic.
Continue Reading >
Podcast
The Bioverge Podcast: Why the FDA Was Right to Approve Biogen's Aduhelm
James Valentine, an attorney with Hyman, Phelps & McNamara specializing in regulatory law, sits down with Neil to discuss the FDA’s accelerated approval of Biogen’s Aduhelm for Alzheimer’s disease and offers a contrarian take on the controversy.
Continue Reading >
Podcast
The Bioverge Podcast: Managing the Challenges of Scaling Cell and Gene Therapies
Amy DuRoss, co-founder and CEO of Vineti, sits down with Neil to discuss how the company’s platform technology addresses the unique supply chain management challenges of cell and gene therapy companies.
Continue Reading >
Podcast
The Bioverge Podcast: Advancing a Pipeline of Off-The-Shelf Cell Therapies
Brian Culley, CEO of Lineage Cell Therapeutics, sits down with Neil to discuss his company’s efforts to develop off-the-shelf cell therapies to treat degenerative retinal disease, spinal cord injury, and cancer.
Continue Reading >
Podcast
The Bioverge Podcast: Improving Epilepsy Outcomes with Digital Health Technology
Rachel Kuperman, CEO of Eysz, sits down with Neil to discuss her company’s efforts to develop a digital health platform using passive eye-movements as input to measure, diagnose, and predict neurological disease starting with epilepsy.
Continue Reading >
Podcast
The Bioverge Podcast: Removing Toxins from Cerebrospinal Fluid to Treat Neurodegenerative Diseases
Anthony DePasqua, CEO of EnClear Therapies, sits down with Neil to discuss the company’s technology in development to remove toxic proteins from cerebrospinal spinal fluid to treat patients with ALS and other neurodegenerative conditions.
Continue Reading >
Podcast
The Bioverge Podcast: Decoding the World
Arvind Gupta, founder of IndieBio and co-lead of the engineering biology practice at the venture capital firm Mayfield, and Po Bronson, author and managing director and partner at IndieBio, sit down with Neil to discuss their new book Decoding the World, IndieBio, and the future of biotech.
Continue Reading >
Podcast
The Bioverge Podcast: Making Long-Term Bets on Longevity
About ten years ago, futurist Sonia Arrison in her book “100 Plus” explored the coming age of longevity and the broad impacts it would have. Now, as a venture investor, she’s backing companies that are positively impacting longevity through her 100 Plus Capital. In this episode, Neil ...
Continue Reading >
Podcast
The Bioverge Podcast: Democratizing Healthcare
Greg Simon, former president of the Biden Cancer Initiative and former executive director of the White House Cancer Moonshot Task Force, discusses his long career in healthcare that has cut across the government, nonprofit, and private sectors.
Continue Reading >
Podcast
The Bioverge Podcast: Shaping the Future of Regenerative Medicine
Soundcloud link: https://soundcloud.com/user-770548556/shaping-the-future-of-regenerative-medicine In November, voters approved a new $5.5 billion bond measure that extends the life of the California Institute for Regenerative Medicine. The measure passed with far less fanfare than the original proposition that established the institute in the midst of a national controversy over embryonic stem cell ...
Continue Reading >